Pfizer
$170M 13F equity value
18 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Pfizer covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ALLO | ALLOGENE THERAPEUTICS INC | 22,032,040 | $47M | 27.5% |
| CELC | CELCUITY INC | 295,652 | $30M | 17.3% |
| ARVN | ARVINAS INC | 3,457,815 | $28M | 16.2% |
| PYXS | PYXIS ONCOLOGY INC | 7,032,770 | $19M | 11.4% |
| WVE | WAVE LIFE SCIENCES LTD | 1,875,000 | $11M | 6.4% |
| BHVN | BIOHAVEN LTD | 505,645 | $8M | 4.7% |
| CRBU | CARIBOU BIOSCIENCES INC | 4,690,431 | $8M | 4.6% |
| SPRO | SPERO THERAPEUTICS INC | 2,362,348 | $5M | 3.1% |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 953,834 | $4M | 2.3% |
| ORIC | ORIC PHARMACEUTICALS INC | 372,904 | $4M | 2.1% |
Track Pfizer's 13F portfolio: $170M in reported holdings, 18 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}